Risk assessment of a local clinical Matchmaker Exchange
implementation: A route to regulatory approval
Sharmini Alagaratnam1, Tor Solli-Nowlan2, Tony Håndstad2.
1Precision Medicine programme, Group Technology and Research, DNV GL, 1363 Høvik, Norway.
2Department of Medical Genetics, Oslo University Hospital, 0424 Oslo, Norway.
